Summary of product characteristics for Isoniazid 100mg and 300mg tablets
Summary of product characteristics for Isoniazid 100mg and 300mg tablets
Public assessment summary report for Isoniazid 100 and 300 mg tablets
Public assessment summary report for Isoniazid 100 and 300 mg tablets
Hemlibra_Emicizumab_ Summary of product characteristics v1
Hemlibra_Emicizumab_ Summary of product characteristics v1
Hemlibra_Emicizumab_ Public assessment summary reportv1
Hemlibra_Emicizumab_ Public assessment summary reportv1
Lumerax DT 20120_ Artemether 20 mg & Lumefantrine 120 mg Dispersible_public assessment summary report
Lumerax DT 20120_ Artemether 20 mg & Lumefantrine 120 mg Dispersible_public assessment summary report
Lumerax DT 20120_ Artemether 20 mg & Lumefantrine 120 mg Dispersible_Summary of product characteristics
Lumerax DT 20120_ Artemether 20 mg & Lumefantrine 120 mg Dispersible_Summary of product characteristics
INIGAST 40 Public assessment summary report v1
INIGAST 40 Public assessment summary report v1
INIGAST 40 Summary of product characteristics v1
INIGAST 40 Summary of product characteristics v1
ALLTERA 50 Summary of product characteristics v1
ALLTERA 50 Summary of product characteristics v1
ALLTERA 50 Public assessment summary report v1
ALLTERA 50 Public assessment summary report v1